Федеральные клинические рекомендации фибрилляция предсердий

1. Беннетт Д.Х. Аритмии сердца. Практические заметки по интерпретации и лечению. Москва: Медпресс-информ; 2016, стр. 32 — 49.

2. Кушаковский М.С. Аритмии сердца. С. Петербург: Фолиант, 2007, стр. 531 — 576.

3. Недоступ А.В., Благова О.В. Как лечить аритмии. Диагностика и терапия нарушений ритма и проводимости в клинической практике. Москва: МЕДпресс-информ; 2007, стр. 21 — 107.

4. Blomstrom-Lindqvist C., Scheinman M., Aliot E.M. et al. ACC/AHA/HRS guidelines for the management of patients with supraventricular tachycardia. JACC; 2016; 67: e27 — 115.

5. Brockmeier K, Ulmer HE, Hessling G. Termination of atrial reentrant tachycardias by using transesophageal atrial pacing. J Electrocardiol. 2002; 35 Suppl: 159 — 163.

6. Camm AJ., Savelieva I, Ho SJ, et al. Atrial fibrillation. In Saksena S, Camm AJ (ed.) Electrophysiological disorders of the heart. Elsevier Saunders; 2012: 559 — 625.

7. Chahadi FK, Singleton CB, McGavigan AD. Incessant atrial tachycardia: cause or consequence of heart failure, and the role of radiofrequency ablation. Int J Cardiol. 2013; 166: e77 — 79.

8. Josephson M.E. Clinical cardiac electrophysiology. Techniques and interpretation. Lippincott Williams and Wilkins, 2008; Chapter 9 — Atrial flutter and fibrillation. pp: 285 — 339; Chapter 10 — Preexcitation Syndromes pp: 339 — 446.

9. Kirchhof P., Benussi S., Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS Eur Heart J 2016; 10: 2 — 60.

10. Kistler PM, Roberts-Thomson KC, Haqqani HM, et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. JACC 2006; 48: 1010 — 1017.

11. Olgin JE, Zipes DP. Specific arrhythmias: diagnosis and treatment. In Bonoow RO, Mann DL, Zipes DP, Libby P, Braunwald E. (ed.) Braunwalds heart disease: a textbook of cardiovascular medicine. Philadelphia: Elsevier Saunders; 2011: 771 — 825.

12. Saoudi N, Cosio F, Waldo A, et al. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol. 2001; 12: 852 — 866.

Читайте также:  Бета блокаторы при фибрилляции предсердий

13. Saxena S, Bharati S, Lindsay BD, Levy S. Paroxysmal supraventricular tachycardia and pre-excitation syndromes. In Saksena S, Camm AJ (ed.) Electrophysiological disorders of the heart. Elsevier Saunders; 2012: 531 — 559.

14. Weinberger BM, Marinchak R, Kowey PR. Наджелудочковые аритмии. В: «Кроуфорд М.Х. (ред.) Диагностика и лечение в кардиологии. Москва: Медпресс-информ; 2007.

15. Диагностика и лечение Фибрилляции предсердий. Рекомендации РКО, ВНОА и АССХ, 2012 год. Всего: 112 страниц.

16. Mikkelsen A.P., Lindhardsen J., Lip G.Y. et al «Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study». J Thromb Haemost 2012; 10: 1745 — 1751.

17. Wagstaff A.J., Overvad T.F., Lip G.Y. Lane D.A. «Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis» QJM 2014; 107: 955 — 967.

18. Friberg L., Rosenqvist M., Lip G.Y. «Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study» Eur Heart J 2012; 33: 1500 — 1510.

19. Hijazi Z., Oldgren J., Lindback J. et al ARISTOTLE and RE-LY Investigators. «The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study» Lancet 2016; 387: 2302 — 2311.

20. Hart R.G., Pearce L.A., Aguilar M.I. «Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation». Ann Intern Med 2007; 146: 857 — 867.

21. Apostolakis S., Sullivan R.M., Olshansky B., Lip G.Y. «Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT(2)R(2) score» Chest 2013; 144: 1555 — 1563

22. Eikelboom J.W., Connolly S.J., Brueckmann M. et al RE-ALIGN Investigators. «Dabigatran versus warfarin in patients with mechanical heart valves.» N Engl J Med 2013; 369: 1206 — 1214.

23. Connolly S.J., Ezekowitz M.D., Yusuf S. et al. RE-LY Steering Committee and Investigators. «Dabigatran versus warfarin in patients with atrial fibrillation» N Engl J Med 2009; 361: 1139 — 1151.

Читайте также:  Фибрилляция предсердий сердцебиение

24. Connolly S.J., Ezekowitz M.D., Yusuf S. et al «Randomized Evaluation of Long-Term Anticoagulation Therapy Investigators. Newly identified events in the RE-LY trial». N Engl J Med 2010; 363: 1875 — 1876.

25. Patel M.R., Mahaffey K.W., Garg J. et al ROCKET AF Investigators. «Rivaroxaban versus warfarin in nonvalvular atrial fibrillation» N Engl J Med 2011; 365: 883 — 891. 33. 319

26. Granger CB, Alexander JH., McMurray, JJV et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2011; 365: 981 — 992

27. Ruff C.T., Giugliano R.P., Braunwald E. et al. «Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials». Lancet 2014; 383: 955 — 962.

28. Pollack C.V. Jr., Reilly P.A., Eikelboom J. et al «Idarucizumab for Dabigatran Reversal» N Engl J Med 2015; 373: 511 — 520

29. Siegal D.M., Curnutte J.T., Connolly S.J. et al «Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.» N Engl J Med 2015; 373: 2413 — 2424.

30. Olesen J.B., Lip G.Y., Kamper A.L. et al «Stroke and bleeding in atrial fibrillation with chronic kidney disease» N Engl J Med 2012; 367: 625 — 635.

31. Albertsen I.E., Rasmussen L.H., Overvad T.F. et al. «Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: A systematic review and meta-analysis». Stroke 2013; 44: 1329 — 1336.

32. Hart R.G., Pearce L.A., Asinger R.W., Herzog C.A. «Warfarin in atrial fibrillation patients with moderate chronic kidney disease» Clin J Am Soc Nephrol 2011; 6: 2599 — 2604.

33. Friberg L., Benson L., Lip G.Y. «Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study» Eur Heart J 2014: 36: 297 — 306.

34. Del-Carpio Munoz F., Gharacholou S.M., Munger T.M. et al «Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation» Am J Cardiol 2016; 117: 69 — 75.

Читайте также:  Клинические протоколы по фибрилляции предсердий

35. ACTIVE Writing Group of the ACTIVE Investigators. «Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial» Lancet 2006; 367: 1903 — 1912.

36. Coppens M., Synhorst D., Eikelboom J.W. et al «Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial» Eur Heart J. 2014; 35 (28): 1856 — 63.

37. Holmes D.R. Jr., Doshi S.K., Kar S. et al «Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis» J Am Coll Cardiol 2015; 65: 2614 — 2623.

38. Paciaroni M., Agnelli G. «Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?» Thromb Haemost 2014; 111: 14 — 18.

39. Connolly S.J., Pogue J., Eikelboom J,. et al ACTIVE Investigators «Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range» Circulation 2008; 118: 2029 — 2037.

40. Kuramatsu J.B., Gerner S.T., Schellinger P.D. et al «Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage» JAMA 2015; 313: 824 — 836.

41. Staerk L., Lip G.Y., Olesen J.B. et al «Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study» BMJ 2015; 351: h5876.

42. Jackson L.R II., Ju C., Zettler M. et al «Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study» JACC Cardiovasc Interv 2015; 8: 1880 — 1889.

Related Post
Adblock
detector